Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6138019 | 6888847 | F | 6138019-5 | 20080807 | 20090324 | 20090331 | EXP | JP-BAYER-200910129BYL | BAYER HEALTHCARE PHARMACEUTICALS INC. | 69 | YR | M | Y | 67 | KG | 20090331 | MD | 20081228 | JAPAN |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
6138019 | 1011355916 | PS | NEXAVAR | 1 | ORAL | TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG | 021923 | ||||
6138019 | 1011355917 | C | TAGAMET | 1 | ORAL | UNIT DOSE: 200 MG | |||||
6138019 | 1011355918 | C | MOBIC | 1 | ORAL | TOTAL DAILY DOSE: 10 MG UNIT DOSE: 10 MG |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
6138019 | 1011355916 | RENAL CELL CARCINOMA STAGE IV |
Outcome of event
Event ID | OUTC COD |
---|---|
6138019 | DE |
6138019 | HO |
Reactions reported
Event ID | PT |
---|---|
6138019 | HEPATIC FUNCTION ABNORMAL |
6138019 | ILEUS |
6138019 | MALIGNANT PLEURAL EFFUSION |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
6138019 | 1011355916 | 20080523 | 20081104 | 120 | DAY |
6138019 | 1011355917 | 20080108 | 20081201 | 11 | MON |
6138019 | 1011355918 | 20080108 | 20081201 | 11 | MON |